speb/financial-data huggingface dataset:
Financial ratios for INGN — annual report dated 2022-12-31
Total revenue: 377241000
Gross profit: 153533000
Operating income: -33082000
Net income: -83772000
Capital expenditures: 21222000
Operating cash flow: -37532000
Depreciation & amortization: 23514000
Net tangible assets: 264377000
Owner earnings: -81480000
Return on net tangible assets (%): -30.81962500520091
Buffett classification: The Gruesome
Stock price: 19.71
Shares outstanding: 27074516
Book value: 297406000
P/B ratio: 1.7943105060422453
Market cap (USD): 533638710.36
Debt to equity: 0.07827347128168229
Current ratio: 4.661815789070988
Quick ratio: 4.1401092595143005
COGS to revenue (%): 59.301083392314204
R&D to revenue (%): 5.816706031422884
SG&A to revenue (%): 43.65167094774958
Free cash flow (dilution-adjusted): -71037000
Buyback yield (%): 0
Retained earnings: -14500000
Inventory turnover: 6.561698882468542
Receivables turnover: 5.86223990303181
Capitalized R&D asset: 21943000
ROCI (R&D-adjusted, %): -5.102750932109262
FCF margin (%): -18.830667928459526
Rule of 40 score: -18.830667928459526
Financial ratios for INGN — annual report dated 2023-12-31
Total revenue: 315660000
Gross profit: 126699000
Operating income: -76492000
Net income: -102449000
Capital expenditures: 26517000
Operating cash flow: -3234000
Depreciation & amortization: 18152000
Net tangible assets: 160164000
Owner earnings: -110814000
Return on net tangible assets (%): -69.18783247171649
Buffett classification: The Gruesome
Stock price: 5.49
Shares outstanding: 27074516
Book value: 204812000
P/B ratio: 0.7257342970138468
Market cap (USD): 148639092.84
Debt to equity: 0.10703962658437982
Current ratio: 2.856254138159347
Quick ratio: 2.554996137717943
COGS to revenue (%): 59.86219349933472
R&D to revenue (%): 6.602040169802953
SG&A to revenue (%): 57.76816828232909
Free cash flow (dilution-adjusted): -37672000
Buyback yield (%): 0
Retained earnings: -116949000
Inventory turnover: 8.65206043956044
Receivables turnover: 7.356327196457702
Capitalized R&D asset: 35541810
ROCI (R&D-adjusted, %): -24.171292326599165
Rosenberg metric: -1.2228956842728889
FCF margin (%): -11.934359754165873
Revenue growth (%): -16.32404749218669
Rule of 40 score: -28.25840724635256
Financial ratios for INGN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.7
Shares outstanding: 27074516
Market cap (USD): 262622805.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INGN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.17
Shares outstanding: 27074516
Market cap (USD): 248273311.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INGN — annual report dated 2024-12-31
Total revenue: 335705000
Gross profit: 154741000
Operating income: -42516000
Net income: -35888000
Capital expenditures: 15003000
Operating cash flow: 5914000
Depreciation & amortization: 21004000
Net tangible assets: 133902000
Owner earnings: -29887000
Return on net tangible assets (%): -22.32005496557184
Buffett classification: The Gruesome
Stock price: 9.17
Shares outstanding: 27074516
Book value: 173860000
P/B ratio: 1.428007084550788
Market cap (USD): 248273311.72
Debt to equity: 0.11161854365581503
Current ratio: 2.41831625068461
Quick ratio: 2.09476305975015
COGS to revenue (%): 53.90566122041673
R&D to revenue (%): 6.43719932678989
SG&A to revenue (%): 52.32183017828152
Free cash flow (dilution-adjusted): -18576000
Buyback yield (%): 0
Retained earnings: -152837000
Inventory turnover: 7.2934064162502015
Receivables turnover: 11.355579609647194
Capitalized R&D asset: 42813990
ROCI (R&D-adjusted, %): -16.152586775566597
Rosenberg metric: 1.3455854126679463
FCF margin (%): -5.533429648054096
Revenue growth (%): 6.350186909966419
Rule of 40 score: 0.8167572619123238
Financial ratios for INGN — quarterly report dated 2025-03-31
Total revenue: 82280000
Gross profit: 36372000
Operating income: -7656000
Net income: -6174000
Capital expenditures: 2038000
Operating cash flow: -16790000
Depreciation & amortization: 5189000
Net tangible assets: 156485000
Owner earnings: -3023000
Return on net tangible assets (%): -1.9318145509154232
Buffett classification: The Gruesome
Stock price: 7.13
Shares outstanding: 27074516
Book value: 197952000
P/B ratio: 0.9751924662544454
Market cap (USD): 193041299.07999998
Debt to equity: 0.09705383123181377
Current ratio: 3.066538326381568
Quick ratio: 2.6651235275244076
COGS to revenue (%): 55.794846864365574
R&D to revenue (%): 4.902771025765678
SG&A to revenue (%): 48.607194944093344
Free cash flow (dilution-adjusted): -20975000
Buyback yield (%): 0
Retained earnings: -159011000
Inventory turnover: 1.7473451832679938
Receivables turnover: 2.2466755863801438
Capitalized R&D asset: 4034000
ROCI (R&D-adjusted, %): -2.010836926523479
FCF margin (%): -25.492221682061256
Rule of 40 score: -25.492221682061256
Financial ratios for INGN — quarterly report dated 2025-06-30
Total revenue: 92277000
Gross profit: 41341000
Operating income: -6129000
Net income: -4152000
Capital expenditures: 3870000
Operating cash flow: 4350000
Depreciation & amortization: 5216000
Net tangible assets: 155432000
Owner earnings: -2806000
Return on net tangible assets (%): -1.8052910597560348
Buffett classification: The Gruesome
Stock price: 7.03
Shares outstanding: 27074516
Book value: 199491000
P/B ratio: 0.9540974153219944
Market cap (USD): 190333847.48000002
Debt to equity: 0.09542786391366026
Current ratio: 3.0285829307568437
Quick ratio: 2.6660702570525436
COGS to revenue (%): 55.199020340930026
R&D to revenue (%): 5.6449602826273075
SG&A to revenue (%): 45.79797782762768
Free cash flow (dilution-adjusted): -1813000
Buyback yield (%): 0
Retained earnings: -163163000
Inventory turnover: 2.095010899518776
Receivables turnover: 2.391091417910448
Capitalized R&D asset: 7911780
ROCI (R&D-adjusted, %): -1.5821497132002693
Rosenberg metric: 1.2317798710956867
FCF margin (%): -1.9647366082555784
Revenue growth (%): 12.149975692756442
Rule of 40 score: 10.185239084500864
Financial ratios for INGN — quarterly report dated 2025-09-30
Total revenue: 92390000
Gross profit: 41316000
Operating income: -7116000
Net income: -5294000
Capital expenditures: 2103000
Operating cash flow: 2167000
Depreciation & amortization: 5219000
Net tangible assets: 154431000
Owner earnings: -2178000
Return on net tangible assets (%): -1.4103385978203857
Buffett classification: The Gruesome
Stock price: 8.17
Shares outstanding: 27074516
Book value: 197175000
P/B ratio: 1.1218399681501205
Market cap (USD): 221198795.72
Debt to equity: 0.09241029542284772
Current ratio: 3.136779379157428
Quick ratio: 2.7506775067750677
COGS to revenue (%): 55.280874553523105
R&D to revenue (%): 5.238662192878017
SG&A to revenue (%): 47.18259551899556
Free cash flow (dilution-adjusted): -1699000
Buyback yield (%): 0
Retained earnings: -168457000
Inventory turnover: 2.0368494516450646
Receivables turnover: 2.2883538911180463
Capitalized R&D asset: 9661250
ROCI (R&D-adjusted, %): -2.769013296520857
Rosenberg metric: -0.004799385678633135
FCF margin (%): -1.8389436086156512
Revenue growth (%): 0.12245738374676246
Rule of 40 score: -1.7164862248688888
Financial ratios for INGN — annual report dated 2025-12-31
Total revenue: 348668000
Gross profit: 154265000
Operating income: -30207000
Net income: -22747000
Capital expenditures: 10383000
Operating cash flow: -11216000
Depreciation & amortization: 20659000
Net tangible assets: 150770000
Owner earnings: -12471000
Return on net tangible assets (%): -8.27153943092127
Buffett classification: The Gruesome
Stock price: 6.72
Shares outstanding: 27074516
Book value: 192231000
P/B ratio: 0.9464693390764236
Market cap (USD): 181940747.51999998
Debt to equity: 0.0909114554884488
Current ratio: 3.121098607066971
Quick ratio: 2.712363264342488
COGS to revenue (%): 55.75590533114596
R&D to revenue (%): 5.5637454541282825
SG&A to revenue (%): 47.34389161035713
Free cash flow (dilution-adjusted): -29613000
Buyback yield (%): 0
Retained earnings: -175584000
Inventory turnover: 7.485964034040586
Receivables turnover: 8.971721174381802
Capitalized R&D asset: 40754900
ROCI (R&D-adjusted, %): -11.392029844790798
Rosenberg metric: -0.022026839426191578
FCF margin (%): -8.493179758394806
Revenue growth (%): 3.861425954334907
Rule of 40 score: -4.631753804059899
Financial ratios for INGN — quarterly report dated 2025-12-31
Total revenue: 81721000
Gross profit: 35236000
Operating income: -9306000
Net income: -7127000
Capital expenditures: 2372000
Operating cash flow: -943000
Depreciation & amortization: 5035000
Net tangible assets: 150770000
Owner earnings: -4464000
Return on net tangible assets (%): -2.9608012204019367
Buffett classification: The Gruesome
Stock price: 6.72
Shares outstanding: 27074516
Book value: 192231000
P/B ratio: 0.9464693390764236
Market cap (USD): 181940747.51999998
Debt to equity: 0.0909114554884488
Current ratio: 3.121098607066971
Quick ratio: 2.712363264342488
COGS to revenue (%): 56.88256384527845
R&D to revenue (%): 6.505059898924389
SG&A to revenue (%): 47.99990210594584
Free cash flow (dilution-adjusted): -5126000
Buyback yield (%): 0
Retained earnings: -175584000
Inventory turnover: 1.790018868651084
Receivables turnover: 2.1027970048632376
Capitalized R&D asset: 10277770
ROCI (R&D-adjusted, %): -3.7134733166734444
Rosenberg metric: -1.256198347107438
FCF margin (%): -6.272561520294662
Revenue growth (%): -11.547786556986688
Rule of 40 score: -17.820348077281352
Financial ratios for IOT.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 55822.83464566929
Buffett classification: The Gruesome
Stock price: 0.14960629921259844
Shares outstanding: 54438232
Market cap (USD): 8144302.425196851
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IOT.V — annual report dated 2022-12-31
Total revenue: 827803.6764705882
Gross profit: 573168.3823529411
Operating income: -103271.32352941176
Net income: -100375.73529411764
Capital expenditures: 52591.17647058823
Operating cash flow: 153229.41176470587
Depreciation & amortization: 83944.85294117646
Net tangible assets: 777579.4117647058
Owner earnings: -69022.0588235294
Return on net tangible assets (%): -8.876528593637117
Buffett classification: The Gruesome
Stock price: 0.10294117647058824
Shares outstanding: 54438232
Book value: 777579.4117647058
P/B ratio: 7.206898179493678
Market cap (USD): 5603935.647058824
Debt to equity: 0.035020066042053585
Current ratio: 4.997132399649113
Quick ratio: 4.742121661272272
Interest coverage ratio: -28.000199362041467
COGS to revenue (%): 30.760348299406743
R&D to revenue (%): 9.857765010707817
SG&A to revenue (%): 73.94833777900949
Free cash flow (dilution-adjusted): 88072.79411764705
Buyback yield (%): 0
Retained earnings: -6170594.852941176
Inventory turnover: 8.215600683241602
Receivables turnover: 5.692882209569271
Capitalized R&D asset: 81602.94117647059
ROCI (R&D-adjusted, %): -5.687891816889292
FCF margin (%): 10.639333530524162
Rule of 40 score: 10.639333530524162
Financial ratios for IOT.V — annual report dated 2023-12-31
Total revenue: 895933.3333333333
Gross profit: 365015.90909090906
Operating income: -287629.5454545454
Net income: -119380.30303030302
Capital expenditures: 32479.545454545452
Operating cash flow: -172790.15151515152
Depreciation & amortization: 59290.90909090909
Net tangible assets: 581009.8484848485
Owner earnings: -92568.93939393939
Return on net tangible assets (%): -15.932421736970504
Buffett classification: The Gruesome
Stock price: 0.06060606060606061
Shares outstanding: 54438232
Book value: 756514.3939393939
P/B ratio: 4.361168557148566
Market cap (USD): 3299286.787878788
Debt to equity: 0
Current ratio: 3.2205765022339747
Quick ratio: 2.8215840703929973
Interest coverage ratio: -681.6355475763015
COGS to revenue (%): 59.258585933747774
R&D to revenue (%): 18.309837717903797
SG&A to revenue (%): 58.03901805464422
Free cash flow (dilution-adjusted): -225855.303030303
Buyback yield (%): 0
Retained earnings: -6476962.878787879
Inventory turnover: 10.00986973661658
Receivables turnover: 5.108738098940784
Capitalized R&D asset: 218717.9099821747
ROCI (R&D-adjusted, %): -20.395866093645427
Rosenberg metric: -2.5507962122577363
FCF margin (%): -25.20894073557962
Revenue growth (%): 8.230170848385415
Rule of 40 score: -16.978769887194204
Financial ratios for IOT.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1037037037037037
Shares outstanding: 54438232
Market cap (USD): 5645446.281481481
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IOT.V — annual report dated 2024-12-31
Total revenue: 1534595.104895105
Gross profit: 776357.3426573427
Operating income: 33642.657342657345
Net income: 157157.34265734267
Capital expenditures: 139951.74825174827
Operating cash flow: -57093.006993006995
Depreciation & amortization: 43106.99300699301
Net tangible assets: 1414046.8531468532
Owner earnings: 60312.587412587425
Return on net tangible assets (%): 4.265246747543505
Capex to operating income (%): 415.99492818391576
Buffett classification: The Gruesome
Stock price: 0.1258741258741259
P/E ratio: 43.601938994816116
Shares outstanding: 54438232
Book value: 1834357.3426573426
P/B ratio: 3.7355670608902116
Market cap (USD): 6852364.867132868
Debt to equity: 0
Current ratio: 3.983017635532332
Quick ratio: 3.67814262810997
Effective tax rate (%): 0
Interest coverage ratio: 4.830705894166081
COGS to revenue (%): 49.40962992903529
R&D to revenue (%): 12.607184145974133
SG&A to revenue (%): 45.980238517619966
Free cash flow (dilution-adjusted): -233264.3356643357
Buyback yield (%): 0
Retained earnings: -5821577.622377623
Inventory turnover: 8.447179806793393
Receivables turnover: 3.0958098446502227
Capitalized R&D asset: 330307.6407514055
ROCI (R&D-adjusted, %): 3.5294815744535244
Rosenberg metric: 2.5075076536575214
FCF margin (%): -15.200383144730553
Revenue growth (%): 71.28451948379028
Rule of 40 score: 56.084136339059725
Financial ratios for IOT.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1258741258741259
Shares outstanding: 54438232
Market cap (USD): 6852364.867132868
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IOT.V — quarterly report dated 2025-03-31
Total revenue: 809919.5804195805
Gross profit: 434426.5734265734
Operating income: 47423.77622377623
Net income: 45610.48951048951
Capital expenditures: 40979.02097902098
Operating cash flow: 130757.34265734267
Depreciation & amortization: 21893.006993006995
Net tangible assets: 1474469.9300699302
Owner earnings: 26524.475524475536
Return on net tangible assets (%): 1.7989160025269253
Capex to operating income (%): 86.41028665801579
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
P/E ratio: 29.21267221685602
Shares outstanding: 54438232
Book value: 1880805.5944055945
P/B ratio: 2.833688465588321
Market cap (USD): 5329617.118881119
Debt to equity: 0
Current ratio: 3.3915023617076443
Quick ratio: 3.1313293576981898
Interest coverage ratio: 8.256148039931825
COGS to revenue (%): 46.361764312264455
R&D to revenue (%): 7.64204336958258
SG&A to revenue (%): 42.19766272227667
Free cash flow (dilution-adjusted): 96578.32167832168
Buyback yield (%): 0
Retained earnings: -5775967.132867133
Inventory turnover: 3.8776313413973647
Receivables turnover: 1.6280614403652571
Capitalized R&D asset: 61894.405594405594
ROCI (R&D-adjusted, %): 4.325974539848003
FCF margin (%): 11.924433488605017
Rule of 40 score: 11.924433488605017
Financial ratios for IOT.V — quarterly report dated 2025-06-30
Total revenue: 718486.8613138685
Gross profit: 382740.1459854014
Operating income: -241318.97810218975
Net income: -174816.78832116787
Capital expenditures: 23947.44525547445
Operating cash flow: -209539.41605839416
Depreciation & amortization: 37622.62773722628
Net tangible assets: 1386910.9489051094
Owner earnings: -161141.60583941604
Return on net tangible assets (%): -11.618742066073423
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
Shares outstanding: 54438232
Book value: 1800024.8175182482
P/B ratio: 5.960308187153949
Market cap (USD): 10728702.656934308
Debt to equity: 0
Current ratio: 2.59118418668939
Quick ratio: 2.3171200155663954
Interest coverage ratio: -43.233555642735716
COGS to revenue (%): 46.72969450192873
R&D to revenue (%): 21.15729833683319
SG&A to revenue (%): 77.86172684483915
Free cash flow (dilution-adjusted): -248489.05109489048
Buyback yield (%): 0
Retained earnings: -6203745.985401459
Inventory turnover: 2.8152706796829574
Receivables turnover: 1.3350789388020834
Capitalized R&D asset: 193481.66050737584
ROCI (R&D-adjusted, %): -7.680430592299974
Rosenberg metric: -0.8350743002505505
FCF margin (%): -34.58505151235311
Revenue growth (%): -11.289110834725715
Rule of 40 score: -45.87416234707882
Financial ratios for IOT.V — quarterly report dated 2025-09-30
Total revenue: 912008.6330935252
Gross profit: 476791.36690647487
Operating income: 68089.20863309353
Net income: 68079.85611510792
Capital expenditures: 41681.29496402878
Operating cash flow: -74061.15107913669
Depreciation & amortization: 17492.805755395686
Net tangible assets: 1623282.0143884893
Owner earnings: 43891.36690647483
Return on net tangible assets (%): 2.703865780402259
Capex to operating income (%): 61.21571362157137
Buffett classification: The Good
Stock price: 0.14388489208633096
P/E ratio: 28.763424247868034
Shares outstanding: 54438232
Book value: 2016102.8776978422
P/B ratio: 3.8851386123880993
Market cap (USD): 7832839.136690648
Debt to equity: 0
Current ratio: 4.7670584297559175
Quick ratio: 4.449418922411419
Interest coverage ratio: 13.401869158878505
COGS to revenue (%): 47.720739738043626
R&D to revenue (%): 10.222514617115198
SG&A to revenue (%): 39.23255806615487
Free cash flow (dilution-adjusted): -180233.8129496403
Buyback yield (%): 0
Retained earnings: -6046403.597122302
Inventory turnover: 4.034546460988508
Receivables turnover: 1.4465425167739283
Capitalized R&D asset: 215503.6835421051
ROCI (R&D-adjusted, %): 2.548111864363369
Rosenberg metric: 0.6187075232134845
FCF margin (%): -19.76229241803214
Revenue growth (%): 26.934629176902558
Rule of 40 score: 7.1723367588704185
Financial ratios for IOT.V — annual report dated 2025-12-31
Total revenue: 3310110.9489051094
Gross profit: 1749663.503649635
Operating income: 17474.452554744523
Net income: 68886.8613138686
Capital expenditures: 340524.0875912408
Operating cash flow: -45513.13868613138
Depreciation & amortization: 104264.23357664233
Net tangible assets: 2279164.2335766423
Owner earnings: -167372.99270072987
Return on net tangible assets (%): -7.343612638132492
Capex to operating income (%): 1948.6967418546367
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
P/E ratio: 155.74381605298015
Shares outstanding: 54438232
Book value: 2662920.4379562037
P/B ratio: 4.028923472144217
Market cap (USD): 10728702.656934308
Debt to equity: 0.04398606326789561
Current ratio: 5.789226897130314
Quick ratio: 5.434009860595543
Effective tax rate (%): 1.1948010921316876
Interest coverage ratio: 0.7256744468020612
COGS to revenue (%): 47.14184718707468
R&D to revenue (%): 11.537686345662438
SG&A to revenue (%): 50.08928626557162
Free cash flow (dilution-adjusted): -477235.76642335765
Buyback yield (%): 0
Retained earnings: -6007650.364963504
Inventory turnover: 11.527643420634023
Receivables turnover: 4.998580290731768
Capitalized R&D asset: 565669.1035934868
ROCI (R&D-adjusted, %): 4.4707098112208925
Rosenberg metric: 5.030805969106517
FCF margin (%): -14.417515720468938
Revenue growth (%): 115.69930324594431
Rule of 40 score: 101.28178752547537
Financial ratios for IOT.V — quarterly report dated 2025-12-31
Total revenue: 820910.9489051094
Gross profit: 429718.9781021897
Operating income: 140209.4890510949
Net income: 127021.89781021897
Capital expenditures: 231513.13868613137
Operating cash flow: 102684.67153284671
Depreciation & amortization: 26041.605839416057
Net tangible assets: 2279164.2335766423
Owner earnings: -78449.63503649633
Return on net tangible assets (%): -3.442035193461554
Capex to operating income (%): 165.11945108206177
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
P/E ratio: 162.8140004233664
Shares outstanding: 54438232
Book value: 2662920.4379562037
P/B ratio: 4.028923472144217
Market cap (USD): 10728702.656934308
Debt to equity: 0.04398606326789561
Current ratio: 5.789226897130314
Quick ratio: 5.434009860595543
Interest coverage ratio: 19.08085824972683
COGS to revenue (%): 47.65339910798757
R&D to revenue (%): 8.61256144144657
SG&A to revenue (%): 46.14652762464345
Free cash flow (dilution-adjusted): -146689.7810218978
Buyback yield (%): 0
Retained earnings: -6007650.364963504
Inventory turnover: 2.8898900518196187
Receivables turnover: 1.239653097126632
Capitalized R&D asset: 183329.79934884212
ROCI (R&D-adjusted, %): 3.4759305573656993
Rosenberg metric: -0.5049048571491346
FCF margin (%): -17.869146612984686
Revenue growth (%): -9.988686606991124
Rule of 40 score: -27.85783321997581
Financial ratios for IPX.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.11256756756756757
Shares outstanding: 121497660
Market cap (USD): 13676696.051351352
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX.L — annual report dated 2022-09-30
Total revenue: 195034444.44444445
Gross profit: 125708888.88888888
Operating income: 72626666.66666667
Net income: 66091111.11111111
Capital expenditures: 884444.4444444444
Operating cash flow: 79194444.44444445
Depreciation & amortization: 4730000
Net tangible assets: 117673333.33333333
Owner earnings: 69936666.66666666
Return on net tangible assets (%): 59.43289332049175
Capex to operating income (%): 1.2177957285355852
Buffett classification: The Great
Stock price: 0.043222222222222224
P/E ratio: 0.07945696133284019
Shares outstanding: 121497660
Book value: 153531111.1111111
P/B ratio: 0.034204135057679226
Market cap (USD): 5251398.86
Debt to equity: 0.06569786796740436
Current ratio: 2.7413720905886865
Quick ratio: 2.7413720905886865
Effective tax rate (%): 18.02257473228683
Interest coverage ratio: 113.87456445993033
COGS to revenue (%): 35.54528829665415
R&D to revenue (%): 0.5583059402612643
SG&A to revenue (%): 5.589326101942106
Free cash flow (dilution-adjusted): 71475555.55555555
Buyback yield (%): 185.79176571376766
Retained earnings: 136632222.2222222
Receivables turnover: 17.215672812867794
Capitalized R&D asset: 1088888.8888888888
ROCI (R&D-adjusted, %): 44.87403449861902
FCF margin (%): 36.647657678700625
Rule of 40 score: 36.647657678700625
Financial ratios for IPX.L — annual report dated 2023-09-30
Total revenue: 217520731.70731708
Gross profit: 139550000
Operating income: 66154878.04878049
Net income: 47831707.317073174
Capital expenditures: 1004878.0487804879
Operating cash flow: 47141463.414634146
Depreciation & amortization: 6186585.365853659
Net tangible assets: 130353658.53658538
Owner earnings: 53013414.63414635
Return on net tangible assets (%): 40.668911965572086
Capex to operating income (%): 1.5189780080004422
Buffett classification: The Great
Stock price: 0.04280487804878049
P/E ratio: 0.1087289752179899
Shares outstanding: 121497660
Book value: 163363414.63414636
P/B ratio: 0.031835111497633586
Market cap (USD): 5200692.519512195
Debt to equity: 0.06525926036518909
Current ratio: 3.14666244190959
Quick ratio: 3.14666244190959
Effective tax rate (%): 24.726519018922964
Interest coverage ratio: 109.14889336016097
COGS to revenue (%): 35.84519557989987
R&D to revenue (%): 0.6542690071593961
SG&A to revenue (%): 7.2569477537885385
Free cash flow (dilution-adjusted): 38167073.17073171
Buyback yield (%): 354.40871091533006
Retained earnings: 144960975.6097561
Receivables turnover: 20.262069748949223
Capitalized R&D asset: 2152726.287262873
ROCI (R&D-adjusted, %): 38.286621881829205
Rosenberg metric: 12.711224489795928
FCF margin (%): 17.54640712687885
Revenue growth (%): 11.529392834647654
Rule of 40 score: 29.075799961526506
Financial ratios for IPX.L — annual report dated 2024-09-30
Total revenue: 226817333.33333334
Gross profit: 143980000
Operating income: 66757333.333333336
Net income: 48636000
Capital expenditures: 1432000
Operating cash flow: 67514666.66666667
Depreciation & amortization: 6104000
Net tangible assets: 144013333.33333334
Owner earnings: 53308000
Return on net tangible assets (%): 37.016017035459676
Capex to operating income (%): 2.145082687544939
Buffett classification: The Great
Stock price: 0.0408
P/E ratio: 0.10192253737971874
Shares outstanding: 121497660
Book value: 174830666.6666667
P/B ratio: 0.0283537472144475
Market cap (USD): 4957104.528
Debt to equity: 0.059371734935899874
Current ratio: 3.134180604943149
Quick ratio: 3.134180604943149
Effective tax rate (%): 25.50393137955683
Interest coverage ratio: 116.98130841121497
COGS to revenue (%): 36.52160622644947
R&D to revenue (%): 0.9276187005108368
SG&A to revenue (%): 7.969408569597855
Free cash flow (dilution-adjusted): 57154666.666666664
Buyback yield (%): 227.04114071218683
Retained earnings: 156902666.66666666
Receivables turnover: 22.032508742390885
Capitalized R&D asset: 3416857.723577236
ROCI (R&D-adjusted, %): 36.22440708958627
Rosenberg metric: 3.1127677806341048
FCF margin (%): 25.198544496893238
Revenue growth (%): 4.273892218478379
Rule of 40 score: 29.472436715371618
Financial ratios for IPX.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 144013333.33333334
Buffett classification: The Gruesome
Stock price: 0.0408
Shares outstanding: 121497660
Book value: 174830666.6666667
P/B ratio: 0.0283537472144475
Market cap (USD): 4957104.528
Debt to equity: 0.059371734935899874
Current ratio: 3.134180604943149
Quick ratio: 3.134180604943149
Buyback yield (%): 0
Retained earnings: 156902666.66666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 121715584.41558442
Buffett classification: The Gruesome
Stock price: 0.021298701298701296
Shares outstanding: 121497660
Book value: 151446753.24675325
P/B ratio: 0.01708681310991819
Market cap (USD): 2587742.3688311684
Debt to equity: 0.05760886342977688
Current ratio: 4.051458211672563
Quick ratio: 4.051458211672563
Buyback yield (%): 0
Retained earnings: 132300000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 121950000
Buffett classification: The Gruesome
Stock price: 0.024054054054054055
Shares outstanding: 121497660
Book value: 155701351.35135135
P/B ratio: 0.018769980194238797
Market cap (USD): 2922511.2810810814
Debt to equity: 0.04985288884645762
Current ratio: 3.3016510105323085
Quick ratio: 3.3016510105323085
Buyback yield (%): 0
Retained earnings: 135054054.05405405
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX.L — annual report dated 2025-09-30
Total revenue: 191720270.27027026
Gross profit: 118585135.13513514
Operating income: 42481081.081081085
Net income: 27424324.324324325
Capital expenditures: 650000
Operating cash flow: 32189189.18918919
Depreciation & amortization: 6954054.054054054
Net tangible assets: 121950000
Owner earnings: 33728378.37837838
Return on net tangible assets (%): 27.65754684573873
Capex to operating income (%): 1.5300928871357677
Buffett classification: The Great
Stock price: 0.024054054054054055
P/E ratio: 0.10656639144574752
Shares outstanding: 121497660
Book value: 155701351.35135135
P/B ratio: 0.018769980194238797
Market cap (USD): 2922511.2810810814
Debt to equity: 0.04985288884645762
Current ratio: 3.3016510105323085
Quick ratio: 3.3016510105323085
Effective tax rate (%): 27.097029133886558
Interest coverage ratio: 74.84761904761905
COGS to revenue (%): 38.146793258759594
R&D to revenue (%): 0.99596117654522
SG&A to revenue (%): 10.228866662437532
Free cash flow (dilution-adjusted): 24340540.54054054
Buyback yield (%): 319.4679365970755
Retained earnings: 135054054.05405405
Receivables turnover: 17.105497950325535
Capitalized R&D asset: 3788785.800922874
ROCI (R&D-adjusted, %): 25.746491532797272
Rosenberg metric: -12.069802692426263
FCF margin (%): 12.695861791884292
Revenue growth (%): -15.473712942160395
Rule of 40 score: -2.7778511502761027
Financial ratios for LEX.AX — annual report dated 2021-06-30
Operating income: -882706.7669172932
Net income: -851879.6992481203
Capital expenditures: 312781.954887218
Net tangible assets: 11040601.503759397
Owner earnings: -1164661.6541353383
Return on net tangible assets (%): -10.548896758376465
Buffett classification: The Gruesome
Stock price: 0.744360902255639
Shares outstanding: 274679578
Book value: 11040601.503759397
P/B ratio: 18.51898544129665
Market cap (USD): 204460738.51127818
Debt to equity: 0
Current ratio: 8.932467532467532
Quick ratio: 8.932467532467532
Free cash flow (dilution-adjusted): -2885714.2857142854
Buyback yield (%): 0.1062762634356428
Retained earnings: -16875939.84962406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.879194630872484
Rule of 40 score: 0
Financial ratios for LEX.AX — annual report dated 2022-06-30
Operating income: -1648965.5172413792
Net income: -1644827.5862068967
Capital expenditures: 14482.758620689656
Depreciation & amortization: 46206.89655172414
Net tangible assets: 13102068.965517242
Owner earnings: -1613103.4482758623
Return on net tangible assets (%): -12.311822297083905
Buffett classification: The Gruesome
Stock price: 0.16551724137931034
Shares outstanding: 274679578
Book value: 13102068.965517242
P/B ratio: 3.4700020381092744
Market cap (USD): 45464206.0137931
Debt to equity: 0.015527950310559008
Current ratio: 9.370292887029288
Quick ratio: 9.370292887029288
Interest coverage ratio: -478.2
Free cash flow (dilution-adjusted): -3877241.379310345
Buyback yield (%): 0.48389715622275586
Retained earnings: -17124137.931034483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.979558094092889
Rule of 40 score: 0
Financial ratios for LEX.AX — annual report dated 2023-06-30
Operating income: -2007947.0198675497
Net income: -1988079.4701986755
Capital expenditures: 15894.039735099337
Depreciation & amortization: 53642.384105960264
Net tangible assets: 13329139.072847681
Owner earnings: -1950331.1258278145
Return on net tangible assets (%): -14.632086252297908
Buffett classification: The Gruesome
Stock price: 0.13245033112582782
Shares outstanding: 274679578
Book value: 13329139.072847681
P/B ratio: 2.7294636855964627
Market cap (USD): 36381401.059602655
Debt to equity: 0.011725542803199682
Current ratio: 1.8835294117647061
Quick ratio: 1.8835294117647061
Interest coverage ratio: -336.8888888888889
Free cash flow (dilution-adjusted): -4682119.205298013
Buyback yield (%): 0.30034995903481393
Retained earnings: -18431788.0794702
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.772948742935101
Rule of 40 score: 0
Financial ratios for LGVN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 120.7
Shares outstanding: 30148947
Market cap (USD): 3638977902.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LGVN — annual report dated 2022-12-31
Total revenue: 1222000
Gross profit: 497000
Operating income: -18043000
Net income: -18835000
Capital expenditures: 569000
Operating cash flow: -13969000
Depreciation & amortization: 893000
Net tangible assets: 18094000
Owner earnings: -18511000
Return on net tangible assets (%): -102.30463136951475
Buffett classification: The Gruesome
Stock price: 32.2
Shares outstanding: 30148947
Book value: 20503000
P/B ratio: 47.348977876408334
Market cap (USD): 970796093.4000001
Debt to equity: 0.12705457737892015
Current ratio: 4.1651263093037585
Quick ratio: 4.1651263093037585
COGS to revenue (%): 59.32896890343699
R&D to revenue (%): 766.7757774140753
SG&A to revenue (%): 750.4091653027824
Free cash flow (dilution-adjusted): -16992000
Buyback yield (%): 0
Retained earnings: -62773000
Receivables turnover: 5.605504587155964
Capitalized R&D asset: 9370000
ROCI (R&D-adjusted, %): -36.96287940506779
FCF margin (%): -1390.5073649754502
Rule of 40 score: -1390.5073649754502
Financial ratios for LGVN — annual report dated 2023-12-31
Total revenue: 709000
Gross profit: 221000
Operating income: -21029000
Net income: -21413000
Capital expenditures: 301000
Operating cash flow: -19002000
Depreciation & amortization: 946000
Net tangible assets: 4454000
Owner earnings: -20768000
Return on net tangible assets (%): -466.2775033677593
Buffett classification: The Gruesome
Stock price: 13.6
Shares outstanding: 30148947
Book value: 6741000
P/B ratio: 60.825645927903864
Market cap (USD): 410025679.2
Debt to equity: 0.3027740691292093
Current ratio: 1.5037284649010028
Quick ratio: 1.5037284649010028
COGS to revenue (%): 68.8293370944993
R&D to revenue (%): 1278.7023977433003
SG&A to revenue (%): 1718.4767277856135
Free cash flow (dilution-adjusted): -21728000
Buyback yield (%): 0
Retained earnings: -84984000
Receivables turnover: 6.387387387387387
Capitalized R&D asset: 15343900
ROCI (R&D-adjusted, %): -76.94900897608595
Rosenberg metric: -0.029455709711846318
FCF margin (%): -3064.59802538787
Revenue growth (%): -41.98036006546645
Rule of 40 score: -3106.5783854533365
Financial ratios for LGVN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.94
Shares outstanding: 30148947
Market cap (USD): 58488957.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LGVN — annual report dated 2024-12-31
Total revenue: 2392000
Gross profit: 1884000
Operating income: -16522000
Net income: -15973000
Capital expenditures: 655000
Operating cash flow: -13868000
Depreciation & amortization: 958000
Net tangible assets: 19486000
Owner earnings: -15670000
Return on net tangible assets (%): -80.41670943241301
Buffett classification: The Gruesome
Stock price: 1.73
Shares outstanding: 30148947
Book value: 21887000
P/B ratio: 2.3830437387490293
Market cap (USD): 52157678.31
Debt to equity: 0.06611230410746105
Current ratio: 7.6003098373353986
Quick ratio: 7.6003098373353986
COGS to revenue (%): 21.237458193979933
R&D to revenue (%): 340.17558528428094
SG&A to revenue (%): 429.30602006688963
Free cash flow (dilution-adjusted): -17188000
Buyback yield (%): 0
Retained earnings: -109607000
Receivables turnover: 28.476190476190474
Capitalized R&D asset: 17303320
ROCI (R&D-adjusted, %): -42.807740216733215
Rosenberg metric: 0.18343260533862785
FCF margin (%): -718.561872909699
Revenue growth (%): 237.37658674188998
Rule of 40 score: -481.185286167809
Financial ratios for LGVN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.73
Shares outstanding: 30148947
Market cap (USD): 52157678.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LGVN — quarterly report dated 2025-03-31
Total revenue: 381000
Gross profit: 275000
Operating income: -5181000
Net income: -5011000
Capital expenditures: 27000
Operating cash flow: -4697000
Depreciation & amortization: 421000
Net tangible assets: 14867000
Owner earnings: -4617000
Return on net tangible assets (%): -31.055357503194998
Buffett classification: The Gruesome
Stock price: 1.55
Shares outstanding: 30148947
Book value: 17158000
P/B ratio: 2.7235614786105606
Market cap (USD): 46730867.85
Debt to equity: 0.07547499708590745
Current ratio: 5.607562408223201
Quick ratio: 5.607562408223201
COGS to revenue (%): 27.821522309711288
R&D to revenue (%): 660.1049868766404
SG&A to revenue (%): 771.9160104986877
Free cash flow (dilution-adjusted): -5187000
Buyback yield (%): 0
Retained earnings: -114618000
Receivables turnover: 13.137931034482758
Capitalized R&D asset: 2515000
ROCI (R&D-adjusted, %): -16.97918180790413
FCF margin (%): -1361.4173228346458
Rule of 40 score: -1361.4173228346458
Financial ratios for LGVN — quarterly report dated 2025-06-30
Total revenue: 316000
Gross profit: 146000
Operating income: -5397000
Net income: -5028000
Capital expenditures: 161000
Operating cash flow: -3597000
Depreciation & amortization: 263000
Net tangible assets: 10335000
Owner earnings: -4926000
Return on net tangible assets (%): -47.66328011611031
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 30148947
Book value: 12656000
P/B ratio: 3.096841901074589
Market cap (USD): 39193631.1
Debt to equity: 0.09007585335018964
Current ratio: 3.4314859926918393
Quick ratio: 3.4314859926918393
COGS to revenue (%): 53.79746835443038
R&D to revenue (%): 934.8101265822784
SG&A to revenue (%): 819.3037974683544
Free cash flow (dilution-adjusted): -4373000
Buyback yield (%): 0
Retained earnings: -119646000
Receivables turnover: 10.193548387096774
Capitalized R&D asset: 4639050
ROCI (R&D-adjusted, %): -23.56378821313463
Rosenberg metric: -0.05129224652087475
FCF margin (%): -1383.860759493671
Revenue growth (%): -17.060367454068242
Rule of 40 score: -1400.9211269477391
Financial ratios for LGVN — quarterly report dated 2025-09-30
Total revenue: 137000
Gross profit: 125000
Operating income: -7310000
Net income: -7221000
Capital expenditures: 57000
Operating cash flow: -5055000
Depreciation & amortization: 264000
Net tangible assets: 7657000
Owner earnings: -7014000
Return on net tangible assets (%): -91.60245526968787
Buffett classification: The Gruesome
Stock price: 0.75
Shares outstanding: 30148947
Book value: 9966000
P/B ratio: 2.268885234798314
Market cap (USD): 22611710.25
Debt to equity: 0.0986353602247642
Current ratio: 2.0931174089068825
Quick ratio: 2.0931174089068825
COGS to revenue (%): 8.75912408759124
R&D to revenue (%): 2811.6788321167883
SG&A to revenue (%): 2615.3284671532847
Free cash flow (dilution-adjusted): -5621000
Buyback yield (%): 0
Retained earnings: -126867000
Receivables turnover: 2.6346153846153846
Capitalized R&D asset: 6661130
ROCI (R&D-adjusted, %): -37.996009984876835
Rosenberg metric: -0.0071090047393364926
FCF margin (%): -4102.919708029197
Revenue growth (%): -56.64556962025317
Rule of 40 score: -4159.56527764945
Financial ratios for LGVN — annual report dated 2025-12-31
Total revenue: 1199000
Gross profit: 803000
Operating income: -23287000
Net income: -22704000
Capital expenditures: 245000
Operating cash flow: -18645000
Depreciation & amortization: 1226000
Net tangible assets: 3390000
Owner earnings: -21723000
Return on net tangible assets (%): -640.7964601769912
Buffett classification: The Gruesome
Stock price: 0.51
Shares outstanding: 30148947
Book value: 5675000
P/B ratio: 2.709420787665198
Market cap (USD): 15375962.97
Debt to equity: 0.14519823788546254
Current ratio: 1.3337411304135063
Quick ratio: 1.3337411304135063
COGS to revenue (%): 33.02752293577982
R&D to revenue (%): 1004.2535446205171
SG&A to revenue (%): 1004.9207673060885
Free cash flow (dilution-adjusted): -20917000
Buyback yield (%): 0
Retained earnings: -132311000
Receivables turnover: 11.528846153846153
Capitalized R&D asset: 20484570
ROCI (R&D-adjusted, %): -78.75141089713364
Rosenberg metric: -0.1328499446970628
FCF margin (%): -1744.5371142618849
Revenue growth (%): -49.87458193979933
Rule of 40 score: -1794.4116962016842
Financial ratios for LGVN — quarterly report dated 2025-12-31
Total revenue: 365000
Gross profit: 257000
Operating income: -5399000
Net income: -5444000
Capital expenditures: 0
Operating cash flow: -5296000
Depreciation & amortization: 278000
Net tangible assets: 3390000
Owner earnings: -5166000
Return on net tangible assets (%): -152.38938053097345
Buffett classification: The Gruesome
Stock price: 0.51
Shares outstanding: 30148947
Book value: 5675000
P/B ratio: 2.709420787665198
Market cap (USD): 15375962.97
Debt to equity: 0.14519823788546254
Current ratio: 1.3337411304135063
Quick ratio: 1.3337411304135063
COGS to revenue (%): 29.589041095890412
R&D to revenue (%): 745.2054794520548
SG&A to revenue (%): 804.3835616438356
Free cash flow (dilution-adjusted): -5736000
Buyback yield (%): 0
Retained earnings: -132311000
Receivables turnover: 3.5096153846153846
Capitalized R&D asset: 6275660
ROCI (R&D-adjusted, %): -47.02404188815866
Rosenberg metric: 0.03426791277258567
FCF margin (%): -1571.5068493150686
Revenue growth (%): 166.42335766423358
Rule of 40 score: -1405.083491650835
Financial ratios for LUMAXTECH.NS — annual report dated 2022-03-31
Total revenue: 195148542.7930898
Gross profit: 54056165.10615852
Operating income: 14877581.432150865
Net income: 10797019.64921535
Capital expenditures: 6167229.328761704
Operating cash flow: 11532098.114202822
Depreciation & amortization: 5209798.232889358
Net tangible assets: 71036898.32520111
Owner earnings: 9839588.553343004
Return on net tangible assets (%): 13.851376939767517
Capex to operating income (%): 41.453171383314704
Buffett classification: The Good
Stock price: 2.1165765528155083
P/E ratio: 13.36118715938432
Shares outstanding: 68157705
Book value: 79744045.89212713
P/B ratio: 1.8090504273116992
Market cap (USD): 144261000.29671633
Debt to equity: 0.27287389711676435
Current ratio: 1.3402040261564574
Quick ratio: 1.1023085400164465
Effective tax rate (%): 27.484730606807812
Interest coverage ratio: 12.091433287246927
COGS to revenue (%): 72.29999039066735
SG&A to revenue (%): 2.4079555002752375
Free cash flow (dilution-adjusted): 4741421.600949492
Buyback yield (%): 0
Retained earnings: 57340076.486878544
Inventory turnover: 9.573489422129638
Receivables turnover: 5.555131192883721
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.86008811080938
FCF margin (%): 2.429647453722819
Rule of 40 score: 2.429647453722819
Financial ratios for LUMAXTECH.NS — annual report dated 2023-03-31
Total revenue: 217547344.70158345
Gross profit: 60195724.725943975
Operating income: 18626991.473812424
Net income: 13575858.708891597
Capital expenditures: 9420950.06090134
Operating cash flow: 16711303.288672352
Depreciation & amortization: 6369098.660170524
Net tangible assets: 39388051.15712546
Owner earnings: 10524007.308160782
Return on net tangible assets (%): 26.71878145526615
Capex to operating income (%): 50.57687428560966
Buffett classification: The Good
Stock price: 3.192082825822168
P/E ratio: 16.025876833519053
Shares outstanding: 68157705
Book value: 103370657.73447019
P/B ratio: 2.104707896285389
Market cap (USD): 217565039.57795373
Debt to equity: 0.7825447748962467
Current ratio: 1.303577197910148
Quick ratio: 1.0904417980982823
Effective tax rate (%): 24.067464521311056
Interest coverage ratio: 9.397801225365182
COGS to revenue (%): 72.32982787791947
SG&A to revenue (%): 2.899146318241617
Free cash flow (dilution-adjusted): 6546004.872107186
Buyback yield (%): 0
Retained earnings: 61273714.981729604
Inventory turnover: 8.019128859711142
Receivables turnover: 3.8728369210006304
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.701922191402888
FCF margin (%): 3.0090024224779888
Revenue growth (%): 11.477821759726089
Rule of 40 score: 14.486824182204078
Financial ratios for LUMAXTECH.NS — annual report dated 2024-03-31
Total revenue: 331051864.73198223
Gross profit: 106063041.13203022
Operating income: 31044537.71435424
Net income: 20021933.085501857
Capital expenditures: 11840448.495023385
Operating cash flow: 31823192.229284085
Depreciation & amortization: 14150065.955150498
Net tangible assets: 59742511.09245713
Owner earnings: 22331550.545628972
Return on net tangible assets (%): 37.379665061397915
Capex to operating income (%): 38.14019910352425
Buffett classification: The Good
Stock price: 5.707533589251439
P/E ratio: 19.42931229429988
Shares outstanding: 68157705
Book value: 121508849.98201224
P/B ratio: 3.201514874936096
Market cap (USD): 389012390.6537908
Debt to equity: 0.7993055697424052
Current ratio: 1.1803202204155487
Quick ratio: 0.9562138459550027
Effective tax rate (%): 26.35962834664006
Interest coverage ratio: 3.7872651066849046
COGS to revenue (%): 67.96180525432224
SG&A to revenue (%): 2.780969568123931
Free cash flow (dilution-adjusted): 19383703.081904303
Buyback yield (%): 0
Retained earnings: 72804329.05624175
Inventory turnover: 7.540384168656744
Receivables turnover: 4.775594873171684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.477940109656892
FCF margin (%): 5.855186194947805
Revenue growth (%): 52.17462901516748
Rule of 40 score: 58.02981521011529
Financial ratios for LUMAXTECH.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 66290886.28762542
Buffett classification: The Gruesome
Stock price: 6.685618729096991
Shares outstanding: 68157705
Book value: 128464930.7214525
P/B ratio: 3.5470881159645047
Market cap (USD): 455676429.0802676
Debt to equity: 0.7141809399164151
Current ratio: 1.0763021018912078
Quick ratio: 0.8551699173358038
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LUMAXTECH.NS — quarterly report dated 2024-12-31
Total revenue: 105559937.05560088
Gross profit: 37130889.38104674
Operating income: 9928488.16878424
Net income: 6531425.5740762325
Capital expenditures: 0
Depreciation & amortization: 3813801.14232428
Owner earnings: 10345226.716400512
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.486653456113765
P/E ratio: 19.531460318722324
Shares outstanding: 68157705
Market cap (USD): 510273117.6990324
Effective tax rate (%): 24.547451143036813
Interest coverage ratio: 4.293841275602539
COGS to revenue (%): 64.82482803917452
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LUMAXTECH.NS — annual report dated 2025-03-31
Total revenue: 425142599.95323825
Gross profit: 150992611.64367548
Operating income: 39296983.86719663
Net income: 26790051.437923778
Capital expenditures: 20151484.68552724
Operating cash flow: 33960053.77601122
Depreciation & amortization: 15036322.188449847
Net tangible assets: 52379798.924479775
Owner earnings: 21674888.940846387
Return on net tangible assets (%): 41.38024464755362
Capex to operating income (%): 51.27997800958155
Buffett classification: The Good
Stock price: 6.271210176216595
P/E ratio: 15.954851530389393
Shares outstanding: 68157705
Book value: 151181879.82230538
P/B ratio: 2.8272653686140066
Market cap (USD): 427431293.1835687
Debt to equity: 0.6976259381888381
Current ratio: 1.1234216479880827
Quick ratio: 0.8654130228355393
Effective tax rate (%): 25.635762004168587
Interest coverage ratio: 4.254253032999131
COGS to revenue (%): 64.48424324913962
SG&A to revenue (%): 2.492126175436659
Free cash flow (dilution-adjusted): 12884615.384615384
Buyback yield (%): 0
Retained earnings: 87340308.62754266
Inventory turnover: 6.3993030588729685
Receivables turnover: 4.589440375648947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.481913509656465
FCF margin (%): 3.03065733380578
Revenue growth (%): 28.42175056087703
Rule of 40 score: 31.45240789468281
Financial ratios for LUMAXTECH.NS — quarterly report dated 2025-03-31
Total revenue: 132439116.20294598
Gross profit: 46450058.45218611
Operating income: 13971241.524433013
Net income: 9314086.976852933
Capital expenditures: 0
Depreciation & amortization: 4340250.175356558
Net tangible assets: 52379798.924479775
Owner earnings: 13654337.15220949
Return on net tangible assets (%): 26.067944956978668
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.271210176216595
P/E ratio: 11.47271048267552
Shares outstanding: 68157705
Book value: 151181879.82230538
P/B ratio: 2.8272653686140066
Market cap (USD): 427431293.1835687
Debt to equity: 0.6976259381888381
Current ratio: 1.1234216479880827
Quick ratio: 0.8654130228355393
Effective tax rate (%): 25.964166272509914
Interest coverage ratio: 5.637982195845697
COGS to revenue (%): 64.92723616411986
Buyback yield (%): 0
Retained earnings: 87340308.62754266
Inventory turnover: 2.0071860797334486
Receivables turnover: 1.4296883617024445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.570867584894691
Revenue growth (%): 25.4634285478848
Rule of 40 score: 25.4634285478848